Beta blocker in HOCM – Cardiology MCQ – Answer

Which of the following beta blockers is not an ideal choice in the treatment of hypertrophic obstructive cardiomyopathy? Correct answer: d) Carvedilol Non vasodilating betablockers are recommended for the treatment of hypertophic obstructive cardiomyopathy (Class I, Level of Evidence B, as per European Society of Cardiology Recomendations 2014). Other class I drug recommendation when beta blockers are not tolerated is verapamil. Disopyramide has a class I recommendation in combination with betablocker or verapamil. Reference 1. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014 Oct 14;35(39):2733-79. Back to question The post Beta blocker in HOCM – Cardiology MCQ – Answer appeared first on Cardiophile MD.
Source: Cardiophile MD - Category: Cardiology Authors: Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs